CNS Co.,Ltd (TYO:4076)

Market Cap	4.32B
Revenue (ttm)	7.00B
Net Income (ttm)	427.00M
Shares Out	2.91M
EPS (ttm)	146.94
PE Ratio	10.11
Forward PE	n/a
Dividend	50.00 (3.34%)
Ex-Dividend Date	May 29, 2025

Volume	3,000
Average Volume	5,605
Open	1,505.00
Previous Close	1,495.00
Day's Range	1,485.00 - 1,505.00
52-Week Range	1,294.00 - 1,920.00
Beta	0.49
RSI	47.50
Earnings Date	Jul 11, 2025

About Longboard Pharmaceuticals

CNS Co.,Ltd., together with its subsidiaries, provides system engineering services in Japan. It offers system integration services, including cloud environment construction, infrastructure environment construction, application development, modernization, data utilization/analysis, SAS introduction support, and ServiceNow implementation support; U-Way oracle cloud infrastructure, U-Way oracle cloud VMware solution, and U-Way Lite OCI base model services; and DX, technology, and business consulting services. The company also provides system infra...

• Industry: Information Technology Services
• Sector: Technology
• Founded: 1985
• Employees: 255
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4076

Financial Performance

In 2025, CNS Co.,Ltd's revenue was 7.00 billion, an increase of 5.21% compared to the previous year's 6.66 billion. Earnings were 427.00 million, a decrease of -7.38%.